Literature DB >> 1370644

Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burst.

A Khwaja1, J E Carver, D C Linch.   

Abstract

Exposure of neutrophils to a range of cytokines augments their response to subsequent agonist-induced activation of the respiratory burst. We have examined the effects of several of these factors, both singly and in combination, on the priming of f-met-leu-phe (FMLP) and complement C5a-stimulated neutrophil H2O2 production, using a whole blood flow cytometric assay designed to minimize artefactual activation. Both granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor alpha (TNF alpha) produced a similar degree of priming of the FMLP-stimulated burst in vitro (558% +/- 86%, n = 41, and 581% +/- 95%, n = 21, of the response seen with FMLP alone, respectively), but with markedly different kinetics (half-maximal response 20 minutes and 7 minutes, respectively). Preincubation with granulocyte colony-stimulating factor (G-CSF) alone caused only modest priming (202% +/- 39%, n = 14). Priming with cytokine combinations of the FMLP-stimulated burst showed that the combinations of G-CSF and TNF alpha and GM-CSF and TNF alpha are highly synergistic, with recruitment of neutrophils unresponsive to priming by single agents. Priming with the combination of GM-CSF and G-CSF was not significantly different to priming with GM-CSF alone. Similar results were obtained using C5a as the respiratory burst stimulus. Significant priming of the FMLP-stimulated respiratory burst was seen in vivo in patients receiving an infusion of GM-CSF (332% +/- 50% of preinfusion response to FMLP, P less than .005, n = 8). Priming was also seen in patients receiving G-CSF (152% +/- 58%, n = 5), although this did not reach conventional significance levels (.05 less than P less than .1). Although GM-CSF infusion caused priming in vivo, this was 48% less than predicted by preinfusion in vitro responses. This result was not due to inadequate GM-CSF levels as addition of further GM-CSF ex vivo did not correct the response. However, these neutrophils were still able to respond appropriately to ex vivo priming with TNF alpha, with a doubling in H2O2 production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370644

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro.

Authors:  S F Khaiboullina; D M Netski; P Krumpe; S C St Jeor
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.

Authors:  Manfred Weiss; Sami Voglic; Britt Harms-Schirra; Ingrid Lorenz; Britta Lasch; Kristoffel Dumon; Wilhelm Gross-Weege; Elisabeth Marion Schneider
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

3.  Src-family kinase-p53/ Lyn p56 plays an important role in TNF-alpha-stimulated production of O2- by human neutrophils adherent to fibrinogen.

Authors:  S R Yan; M J Novak
Journal:  Inflammation       Date:  1999-04       Impact factor: 4.092

4.  A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation.

Authors:  T Betsuyaku; F Liu; R M Senior; J S Haug; E J Brown; S L Jones; K Matsushima; D C Link
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides.

Authors:  C Elbim; S Bailly; S Chollet-Martin; J Hakim; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Flare of arthritis with successful treatment of Felty's syndrome with granulocyte colony stimulating factor (GCSF).

Authors:  S Q Hayat; M Hearth-Holmes; R E Wolf
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

7.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

Review 8.  Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane.

Authors:  Jamel El-Benna; Pham My-Chan Dang; Marie-Anne Gougerot-Pocidalo
Journal:  Semin Immunopathol       Date:  2008-06-07       Impact factor: 9.623

9.  Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.

Authors:  M B Klein; S F Hayes; J L Goodman
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

10.  Effect of adalimumab on neutrophil function in patients with rheumatoid arthritis.

Authors:  Franco Capsoni; Piercarlo Sarzi-Puttini; Fabiola Atzeni; Francesca Minonzio; Paola Bonara; Andrea Doria; Mario Carrabba
Journal:  Arthritis Res Ther       Date:  2005-01-10       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.